BIOsens

Company |

followers

About your organization

BIOsens unique value proposition is that we make mycotoxins testing process accurate, rapid, and easy to perform at the same time.

BIOsens device provides customers with the ability to get quantitative results onsite with the same accuracy as laboratory solutions within only 21 minutes instead of days when they need to send samples to the laboratory. Therefore, clients save money avoiding mycotoxins contamination in crops, protect the animals’ health from mycotoxicosis, improve the process of decision-making by proceeding with the operations faster, and ensuring the quality of supplies.

BIOsens developed the world’s first portable mycotoxins detection device allowing farmers, traders, and food processing companies (grains) to test products for mycotoxin contamination 100 times faster and onsite.

The product consists of a detection device with unique optical elements, disposable cartridges and software, developed utilizing a set of proprietary AI algorithms. The testing process conducts advanced analytics and predicts future mycotoxins contamination.

News

Andrii Karpiuk (Start Up Ceo, BIOsens )

Published 3 years ago

BIOsens is ready for investment

I am proud to share that we have emerged as a TOP 100 Global startup of SLINGSHOT 2020, after battling with more than 7,500 global startups.

And at the end of the year, BIOsens was in the FoodTech TOP-500 world’s first list of the global entrepreneurial talent between food, technology and sustainability!

This year we strengthened the team with + 5 people (CTO - grate manager which has experience working with more that 40 Tech startups - Denis Galamaga, 2 electronics Engineers (Senior, Middle, June), 1 Chemical Analytics - Roman Palonko, 1 Mechanical Engineer Arsen Starostin), receive PCT patent registration in EU & 2 patents in Ukraine, +15 customers interested.

Last month we lost the grant deal with European Commission of 1M EUR grant support, we were very close (from more than 4200 startups they selected 142 & we were in that number, after they financed half of them, and we were not).

So, we actively started fundraising in January of the seed round (1,3M eur). We already have a commitment of 15% of it. If you have any advice I would be happy to have a quick call.

BIOsens is ready for investments

Best regards,

Andrii Karpiuk, BIOsens